XML 45 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Note 6 - Fair Value (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Fair Value, by Balance Sheet Grouping [Table Text Block]

ASSETS

 

LEVEL 1
QUOTED PRICES

  

LEVEL 2 OTHER
SIGNIFICANT
OBSERVABLE INPUTS

  

LEVEL 3 SIGNIFICANT
OBSERVABLE INPUTS

 

Common Stocks

            

Advanced Materials

 $  $  $167,642 
Automotive        0 

Total Common Stocks

        167,642 

Preferred Stocks

            
Automotive        0 
Medical Devices        0 
Semiconductor Equipment        0 

Total Preferred Stocks

        0 

Convertible Notes and Non-Convertible Notes

            
Automotive        0 

Medical Devices

        1,523 
Semiconductor Equipment        0 

Total Convertible and Non-Convertible Notes

        1,523 

Investment Companies

  56,271       

Total

 $56,271  $  $169,165 

ASSETS

 

LEVEL 1
QUOTED PRICES

  

LEVEL 2 OTHER
SIGNIFICANT
OBSERVABLE INPUTS

  

LEVEL 3 SIGNIFICANT
OBSERVABLE INPUTS

 

Common Stocks

            

Advanced Materials

 $-  $-  $260,497 
Automotive  -   -   0 
Equipment Leasing  -   -   0 

Total Common Stocks

  -   -   260,497 

Preferred Stocks

            
Automotive  -   -   - 

Equipment Leasing

  -   -   29,466 
Medical Equipment  -   -   0 
Semiconductor Equipment  -   -   0 

Total Preferred Stocks

  -   -   29,466 

Convertible and Non-Convertible Notes

            
Automotive  -   -   0 

Medical Devices

  -   -   25,287 
Semiconductor Equipment  -   -   0 

Total Convertible and Non-Convertible Notes

  -   -   25,287 

Investment Companies

  745,224   -   - 

Total

 $745,224  $-  $315,250 
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS
(LEVEL 3)

 

BALANCE
AS OF 12/31/24

  

NET PURCHASES/
CONVERSIONS

  

NET
SALES/
CONVERSIONS

  

NET
REALIZED GAINS/
(LOSSES)

  

NET
UNREALIZED APPRECIATION (DEPRECIATION)(1)

  

TRANSFERS IN (OUT) OF LEVEL 3

  

BALANCE
AS OF 12/31/25

 

Common Stocks

                            

Advanced Materials

 $260,497  $  $  $  $(92,855) $  $167,642 

Equipment Leasing

           (20,000)  20,000       

Total Common Stocks

  260,497         (20,000)  (72,855)     167,642 

Preferred Stocks

                            

Equipment Leasing

  29,466      (8,623)  (1,921,377)  1,900,534       

Total Preferred Stocks

  29,466      (8,623)  (1,921,377)  1,900,534       

Convertible and Non-Convertible Notes

                            

Automotive

           (24,129,015)  24,129,015       

Medical Devices

  25,287            (23,764)     1,523 

Total Convertible and Non-Convertible Notes

  25,287         (24,129,015)  24,105,251      1,523 

Total

 $315,250  $  $(8,623) $(26,070,392) $25,932,930  $  $169,165 

INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS
(LEVEL 3)

 

BALANCE
AS OF 12/31/23

  

NET PURCHASES/
CONVERSIONS

  

NET
SALES/
CONVERSIONS

  

NET
REALIZED GAINS/
(LOSSES)

  

NET
UNREALIZED APPRECIATION (DEPRECIATION)(1)

  

TRANSFERS IN (OUT) OF LEVEL 3

  

BALANCE
AS OF 12/31/24

 

Common Stocks

                            

Advanced Materials

 $299,932  $-  $-  $-  $(39,435) $-  $260,497 

Equipment Leasing

  55   -   -   -   (55)  -   - 

Semiconductor Equipment

  -   -   -   -   (3,862,405)  3,862,405   - 

Total Common Stocks

  299,987   -   -   -   (3,901,895)  3,862,405   260,497 

Preferred Stocks

                            

Aerospace

  -   2,441   (156,405)  (11,083,138)  11,237,102   -   - 

Equipment Leasing

  110,172   -   (20,000)  -   (60,706)  -   29,466 

Total Preferred Stocks

  110,172   2,441   (176,405)  (11,083,138)  11,176,396   -   29,466 

Convertible and Non-Convertible Notes

                            

Advanced Materials

  100,000   -   (100,000)  -   -   -   - 

Aerospace

  4,200,000   -   (5,956,261)  (603,530)  2,359,791   -   - 

Automotive

  -   -   (40,000)  -   40,000   -   - 

Medical Devices

  87,713   -   -   -   (62,426)  -   25,287 

Total Convertible and Non-Convertible Notes

  4,387,713   -   (6,096,261)  (603,530)  2,337,365   -   25,287 

Total

 $4,797,872  $2,441  $(6,272,666) $(11,686,668) $9,611,866  $3,862,405  $315,250 
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
 

FAIR
VALUE AT
12/31/25

VALUATION TECHNIQUES(1)

UNOBSERVABLE INPUTS

RANGE
(WEIGHTED AVG.)(2)

Direct venture capital investments: Advanced Materials$0.2M

Market Comparable Companies 

Option Pricing Model

 Revenue Multiple(3) 

 Years to Maturity(3)

 Volatility(3)

 Risk-Free Rate(3)

 Discount for Lack of Marketability(4)

0.8x – 0.9x (0.9x)

5 years (5 years)

 50.0% (50%)

3.73% (3.73%)

22.8% (22.8%)

     

Direct venture capital investments: Automotive

$0.0M

Liquidation Value

 Market Value of Invested Capital(3)

$0 ($0)

Direct venture capital investments: Medical Devices

$0.0M

Market Comparable Companies

Market Comparable Transactions

 Revenue Multiple(3) 

 Risk Free Rate(3)

 Going Concern Probability(2)

 Volatility(3) 

0.4x – 0.5x (0.5x)

3.55% (3.55%)

5% (5%)

55% (55%)

Direct venture capital investments: Semiconductor Equipment

$0.0MRecent Transactions Equity Proceeds from Private Transactions(3)  $0 ($0)
 

FAIR
VALUE AT
12/31/24

VALUATION TECHNIQUES(1)

UNOBSERVABLE INPUTS

RANGE
(WEIGHTED AVG.)(2)

Direct venture capital investments: Advanced Materials

$0.3M

Market Comparable Companies 

Option Pricing Model

Revenue Multiple(3) 

Years to Maturity(3)

Volatility(3)

Risk-Free Rate(3)

Discount for Lack of   Marketability(4)

0.8x – 1.0x (1.0x)

5 years (5 years)

50.0% (50%)

4.38% (4.38%)

22.8% (22.8%)

     

Direct venture capital investments: Automotive

$0.0M

Liquidation Value

Market Value of Invested Capital(3)

$0 ($0)

Direct venture capital investments: Equipment Leasing

$0.0M

Cash Value

Option Pricing Model

Years to Maturity(3) 

Volatility(3) 

Risk-Free Rate(3) 

5 years (5 years)

50.0% (50.0%)

4.38% (4.38%)

Direct venture capital investments: Medical Devices

$0.0M

Market Comparable Companies

Market Comparable Transactions

Revenue Multiple(3) 

Risk Free Rate(3)

Going Concern Probability(2)

Volatility(3) 

0.7x – 1.1x (0.9x)

4.27% (4.27%)

10% (10%)

55% (55%)

Direct venture capital investments: Semiconductor Equipment

$0.0M

Recent Transactions

Equity Proceeds from Private Transactions(3)  

$0 ($0)